English 
オリンパス株式会社 has launched SecureFlex. This is a single-use fine needle biopsy (FNB) device. It’s designed for endoscopic ultrasound-guided procedures (EUS-FNB) in the GI tract. SecureFlex is mainly for diagnosing pancreatic cancer. It enables accurate tissue sampling from hard-to-reach submucosal and extramural lesions.
EUS-FNB uses endoscopy and ultrasound. This lets doctors see inside the body clearly and gather the right tissue samples. To treat pancreatic cancer well, you need high-quality samples. This is especially true for targeted therapies and immunotherapies. Accurate diagnosis and treatment plans rely on these samples.
SecureFlex meets these needs with its Dual-Beveled Raptor Tip. This tip has multi-dimensional cutting surfaces. They help capture larger, intact tissue samples. Plus, it keeps the cellular structure intact. This achieves better diagnostic accuracy. The device has a flexible nitinol design and a multi-layer sheath. It easily navigates tough spots like the pancreatic head and uncinate process. This means you don’t need to keep using a scope! changes. The needle features a houndstooth pattern. This design improves ultrasound visibility during procedures.
こちらもお読みください： Japan’s Digital Therapeutics Market Poised for Takeoff — What It Means for Tech Players
SecureFlex combines flexibility, precision, and quality sampling. This support leads to more effective EUS-FNB procedures. It also helps plan treatments for pancreatic cancer and other gut issues. The device will be available in Europe and Japan starting Autumn 2025. Global availability will depend on regulatory approvals.
日本語